These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29398624)

  • 1. Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017.
    Ciccocioppo R; Dos Santos CC; Baumgart DC; Cangemi GC; Cardinale V; Ciacci C; De Coppi P; Haldar D; Klersy C; Nostro MC; Ott M; Piemonti L; Tomei AA; Uygun B; Vetrano S; Orlando G
    Cytotherapy; 2018 Mar; 20(3):461-476. PubMed ID: 29398624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regenerative medicine: future impact on clinical therapies and society.
    Kargul J; Laurent GJ; Irminger-Finger I
    Int J Biochem Cell Biol; 2014 Nov; 56():1. PubMed ID: 25461768
    [No Abstract]   [Full Text] [Related]  

  • 3. Transplantation of umbilical cord blood-derived cells for novel indications in regenerative therapy or immune modulation: a scoping review of clinical studies.
    Iafolla MA; Tay J; Allan DS
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):20-5. PubMed ID: 24067504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Institutional profile. The International Society for Cellular Therapy: evolving to meet the demands of the regenerative medicine industry.
    Maziarz RT; Arthurs J; Horwitz E
    Regen Med; 2011 Mar; 6(2):163-6. PubMed ID: 21391849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-based therapies for the preterm infant.
    Zhu D; Wallace EM; Lim R
    Cytotherapy; 2014 Dec; 16(12):1614-28. PubMed ID: 25154811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings of the signature series symposium "cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies-promise, facts and fantasy," international society for cellular therapies, montreal, canada, may 2, 2018.
    Piuzzi NS; Dominici M; Long M; Pascual-Garrido C; Rodeo S; Huard J; Guicheux J; McFarland R; Goodrich LR; Maddens S; Robey PG; Bauer TW; Barrett J; Barry F; Karli D; Chu CR; Weiss DJ; Martin I; Jorgensen C; Muschler GF
    Cytotherapy; 2018 Nov; 20(11):1381-1400. PubMed ID: 30316562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparing regenerative therapies for clinical application: proposals for responsible translation.
    Shapiro SA; Smith CG; Arthurs JR; Master Z
    Regen Med; 2019 Feb; 14(2):77-84. PubMed ID: 30651044
    [No Abstract]   [Full Text] [Related]  

  • 8. Computational Strategies for Niche-Dependent Cell Conversion to Assist Stem Cell Therapy.
    Del Sol A; Okawa S; Ravichandran S
    Trends Biotechnol; 2019 Jul; 37(7):687-696. PubMed ID: 30782480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cells, a two-edged sword: risks and potentials of regenerative medicine.
    Piscaglia AC
    World J Gastroenterol; 2008 Jul; 14(27):4273-9. PubMed ID: 18666313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organizational profile: UK regenerative medicine platform immunomodulation hub.
    Asante CO
    Regen Med; 2015; 10(3):259-63. PubMed ID: 25933235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced cell therapeutics are changing the clinical landscape: will mesenchymal stromal cells be a part of it?
    Schäfer R
    BMC Med; 2019 Mar; 17(1):53. PubMed ID: 30832655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulating cell-based regenerative medicine: the challenges ahead.
    Ali RR; Hollander AP; Kemp P; Webster A; Wilkins MR
    Regen Med; 2014 Jan; 9(1):81-7. PubMed ID: 24351008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regenerative medicine and the gut.
    Peterson J; Pasricha PJ
    Gastroenterology; 2011 Oct; 141(4):1162-6, 1166.e1-2. PubMed ID: 21864477
    [No Abstract]   [Full Text] [Related]  

  • 14. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine.
    Harris DT; Rogers I
    Curr Stem Cell Res Ther; 2007 Dec; 2(4):301-9. PubMed ID: 18220914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Translation of Regenerative Therapies.
    Allickson JG
    Clin Pharmacol Ther; 2017 Jan; 101(1):28-30. PubMed ID: 27806427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational Cell Therapies in Regenerative Medicine and Cancers.
    Lin SZ
    Cell Transplant; 2016; 25(5):781-2. PubMed ID: 27102174
    [No Abstract]   [Full Text] [Related]  

  • 17. [Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine].
    Osakada F
    Yakugaku Zasshi; 2017; 137(1):23-29. PubMed ID: 28049891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-based therapy approaches: the hope for incurable diseases.
    Buzhor E; Leshansky L; Blumenthal J; Barash H; Warshawsky D; Mazor Y; Shtrichman R
    Regen Med; 2014; 9(5):649-72. PubMed ID: 25372080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The advancement of human pluripotent stem cell-derived therapies into the clinic.
    Thies RS; Murry CE
    Development; 2015 Sep; 142(18):3077-84. PubMed ID: 26395136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial regeneration therapy in heart failure: Current status and future therapeutic implications in clinical practice.
    Banovic M; Pusnik-Vrckovnik M; Nakou E; Vardas P
    Int J Cardiol; 2018 Jun; 260():124-130. PubMed ID: 29622425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.